419 related articles for article (PubMed ID: 18036789)
1. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E
Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
3. Local neurotoxicity and myotoxicity evaluation of cyclodextrin complexes of bupivacaine and ropivacaine.
Cereda CM; Tofoli GR; Maturana LG; Pierucci A; Nunes LA; Franz-Montan M; de Oliveira AL; Arana S; de Araujo DR; de Paula E
Anesth Analg; 2012 Nov; 115(5):1234-41. PubMed ID: 22822189
[TBL] [Abstract][Full Text] [Related]
4. Study of the interaction between S(--) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin.
Moraes CM; Abrami P; de Paula E; Braga AF; Fraceto LF
Int J Pharm; 2007 Feb; 331(1):99-106. PubMed ID: 17071028
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
8. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
[TBL] [Abstract][Full Text] [Related]
9. Sufentanil-2-hydroxypropyl-β-cyclodextrin inclusion complex for pain treatment: physicochemical, cytotoxicity, and pharmacological evaluation.
Volobuef C; Moraes CM; Nunes LA; Cereda CM; Yokaichiya F; Franco MK; Braga AF; De Paula E; Tófoli GR; Fraceto LF; De Araujo DR
J Pharm Sci; 2012 Oct; 101(10):3698-707. PubMed ID: 22736497
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and local toxicity studies of a liposomal formulation for the novel local anaesthetic ropivacaine.
de Araujo DR; Cereda CM; Brunetto GB; Vomero VU; Pierucci A; Neto HS; de Oliveira AL; Fraceto LF; Braga Ade F; de Paula E
J Pharm Pharmacol; 2008 Nov; 60(11):1449-57. PubMed ID: 18957165
[TBL] [Abstract][Full Text] [Related]
11. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
13. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
14. Clonidine complexation with hydroxypropyl-beta-cyclodextrin: From physico-chemical characterization to in vivo adjuvant effect in local anesthesia.
Braga MA; Martini MF; Pickholz M; Yokaichiya F; Franco MK; Cabeça LF; Guilherme VA; Silva CM; Limia CE; de Paula E
J Pharm Biomed Anal; 2016 Feb; 119():27-36. PubMed ID: 26637952
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
16. Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-beta-cyclodextrin.
Grillo R; de Melo NF; Moraes CM; de Lima R; Menezes CM; Ferreira EI; Rosa AH; Fraceto LF
J Pharm Biomed Anal; 2008 Jun; 47(2):295-302. PubMed ID: 18289821
[TBL] [Abstract][Full Text] [Related]
17. Complexation of oxethazaine with 2-hydroxypropyl-β-cyclodextrin: increased drug solubility, decreased cytotoxicity and analgesia at inflamed tissues.
Prado AR; Yokaichiya F; Franco MKKD; Silva CMGD; Oliveira-Nascimento L; Franz-Montan M; Volpato MC; Cabeça LF; de Paula E
J Pharm Pharmacol; 2017 Jun; 69(6):652-662. PubMed ID: 28211640
[TBL] [Abstract][Full Text] [Related]
18. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
Hu L; Zhang H; Song W; Gu D; Hu Q
Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
[TBL] [Abstract][Full Text] [Related]
19. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
20. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
Garnero C; Zoppi A; Genovese D; Longhi M
Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
